Abstract 395P
Background
Google Trends, a free web-based tracking system of Google search volumes, can be used to monitor online interest in various health conditions, including lung cancer. This is particularly useful in the Philippines, the country named as the world's number one internet user in 2018. Understanding the pattern of information-seeking behavior of Filipinos with regards to lung cancer is crucial because it may inform public policy and potentially make lung cancer awareness campaigns more directed and effective in the population-based setting. Here we described patterns in online search behaviors related to lung cancer using Google Trends data on Google web and YouTube searches in the Philippines for the past ten years.
Methods
Relative search volumes on the term “lung cancer” from 2009 to 2019 were extracted from Google Trends. Both Google web search and YouTube search data were downloaded. The data were saved in a comma-separated values file then imported to Microsoft Excel where a graph was plotted and a polynomial trendline (second order) was added to estimate search trends over a time period. Regions and cities in the Philippines where the term “lung cancer” was most popular were identified. Related topics and queries were also enumerated.
Results
Trends in Google web search showed a steady interest in lung cancer for both Google web search and YouTube searches from 2009 to 2019, with peaks in 2014. No spikes were observed in August, the Philippines’ Lung Cancer Awareness month. Online search behaviour for lung cancer was greatest in Metro Manila and areas in Northern Philippines. Top related and rising topics and queries in lung cancer, both on Google web search and YouTube, were related to etiology, symptoms, and management of lung cancer.
Conclusions
Filipinos had a steady interest in lung cancer, as shown by Google Trends data for both Google web search and YouTube searches from 2009 to 2019. Cancer diagnoses of Filipino personalities in 2014 may have led to peaks in online interest. Filipinos were also interested to learn about etiology, symptoms, and management of lung cancer. These data may be used to leverage online interest to optimize lung cancer awareness campaigns in the Philippines.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
508P - Efficacy and safety of anti-PD-1 antibody SHR-1210 combined with apatinib in first-line treatment for advanced lung squamous carcinoma: A phase II study
Presenter: Jinliang Wang
Session: Poster display session
Resources:
Abstract
525P - Retrospective analysis of outcomes of cisplatin and irinotecan combination chemotherapy for unresectable thymic carcinoma
Presenter: Akito Fukuda
Session: Poster display session
Resources:
Abstract
524P - A study in recurrent small cell lung cancer patients, comparing weekly paclitaxel, irinotecan and temozolomide in second-line: A prospective study from a south Indian tertiary cancer hospital
Presenter: LALATENDU MOHARANA
Session: Poster display session
Resources:
Abstract
505P - PD-L1 expression in ALK rearranged NSCLC: All questions answered?
Presenter: Amrith B P
Session: Poster display session
Resources:
Abstract
487P - Afatinib versus gefitinib or erlotinib in first-line setting for Malaysia patients with EGFR mutant advanced lung adenocarcinoma
Presenter: Chee Shee Chai
Session: Poster display session
Resources:
Abstract
492P - Feasibility of rebiopsy and sequential treatment of EGFR tyrosine kinase inhibitors in real world patients with EGFR mutant non-small cell lung cancer
Presenter: Heekyung Ahn
Session: Poster display session
Resources:
Abstract
513P - Phase II study of vitamin B12 and folate supplementation for patients undergoing chemotherapy with pemetrexed
Presenter: Shingo Kitagawa
Session: Poster display session
Resources:
Abstract
493P - Is exon 19 deletion different from exon 21 mutation in advanced non-small cell lung cancer: A single centre experience
Presenter: Sarita Shrivastva
Session: Poster display session
Resources:
Abstract
494P - Comparison of pattern of disease progression and prevalence of acquired T790M mutation in Malaysia patients with EGFR mutant lung adenocarcinoma upon failure of first-line afatinib, gefitinib and erlotinib
Presenter: Chee Shee Chai
Session: Poster display session
Resources:
Abstract
517P - High BRCA1 expression is independently correlated with decreased overall survival in lung adenocarcinoma: Evidence from meta and bioinformatics analyses
Presenter: Fengzhu Guo
Session: Poster display session
Resources:
Abstract